Clinical Trials Directory

Trials / Completed

CompletedNCT00316121

Safety and Efficacy Study of Healos as a Bone Replacement to Treat Degenerative Disc Disease

A Prospective, Multicenter, Randomized Study Comparing the Use of HEALOS® to Autograft in a Transforaminal Lumbar Interbody Fusion (TLIF) Approach

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
138 (actual)
Sponsor
Advanced Technologies and Regenerative Medicine, LLC (ATRM) · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the safety and effectiveness of HEALOS compared with autograft using the transforaminal lumbar interbody fusion (TLIF) method.

Conditions

Interventions

TypeNameDescription
DEVICEHEALOS and Leopard CagePlacement in interbody space
DEVICELeopard Cage and AutograftPlacement in the interbody space

Timeline

Start date
2006-04-01
Primary completion
2010-01-01
First posted
2006-04-20
Last updated
2011-03-03
Results posted
2011-03-03

Locations

17 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00316121. Inclusion in this directory is not an endorsement.

Safety and Efficacy Study of Healos as a Bone Replacement to Treat Degenerative Disc Disease (NCT00316121) · Clinical Trials Directory